结论采用均匀设计法优选的配方组成符合骨架控释型透皮给药系统的要求。
Conclusion the prescription composition optimized by uniform design meets the requirement of skeleton-controlled transdermal delivery system.
以对乙酰氨基酚为模型药物，采用甲醛蒸汽交联明胶胶囊的方法制备了胃内滞留型控释胶囊。
A laboratory method of preparing controlled release capsules floated in artificial gastric juice was developed by crosslinking the gelatin capsules with formaldehyde vapor.
我们对渗透泵型控释制剂的研究，从包衣膜和片芯处方两个方面着手。
Our research in osmotic pump formulations will start from two aspects, the core prescription and the coating film.
目的探讨格列吡嗪控释片对2型糖尿病患者血管内皮功能的影响。
Objective To study the effect of glipizide-XL on endothelium-dependent relaxing function in type 2 diabetic patients.
研究了水蒸气压差与包膜型控释肥料养分释放速率的关系。
The relationship between vapor pressure difference and rate of nutrient release from film coated controlled release fertilizer was discussed.
目的：观察硝苯地平控释片与舒氟美联合使用对喘息型慢性支气管炎的疗效。
Purpose:observation of nifedipine GITS and sulpiride the use of fluoride-US joint chronic asthmatic bronchitis effect.
目的制备盐酸昂丹司琼渗透泵型控释片剂(OND - OPT)并考察体外释药特性。
Aim To prepare ondansetron hydrochloride osmotic pump tablets (OND-OPT) and investigate their in vitro drug release behavior.
阐述了靶向型药物控释体系控制释药的原理和相关材料。
Expounding the mechanism and relative material of the drug control release in the systems for drug targeting and controlled release.
结论格列齐特控释片治疗2型糖尿病的临床疗效和对生存质量的影响与格列齐特普通片相似。
Conclusion Controlled-release-gliclazide had the similar effect on the patients with type 2 diabetes as ordinary gliclazide tablets did in improving their clinical manifestation and quality of life.
以HPMC醇性凝胶为储库递质，EVA为控释膜，热封法制备储库型贴片。
The reservoir patches were prepared by hot-envelop method with HPMC ethanol gel as reservoir medium and EVA as control release membrane.
目的制备苦参碱渗透泵型控释片，同时建立一种新的设计初级渗透泵处方的方法。
Objective To prepare controlled release tablets of matrine, and establish a new method for preparation of elementary osmotic pump tablets.
本文就口服渗透泵型控释片的制备工艺研究进展情况进行了综述。
This paper reviewed the recent progress in preparation craft of osmotic pump controlled release tablets.
本发明也包括利用该药物组合物制备的硬胶囊、软胶囊、缓控释胶囊、渗透泵型胶囊或其他合适的剂型。
The invention also includes capsules, soft capsules, controlled-release capsule, osmotic pump capsules or other proper types of preparation which are prepared through the medicine combination.
目的研究渗透泵型控释片剂的释药规律及释药重现性，探索考察释药机制的新方法。
OBJECTIVE to improve the drug release reproducibility of elementary osmotic pump tablets and to investigate its drug release mechanism with a new method.
目的研究渗透泵型控释片剂的释药规律及释药重现性，探索考察释药机制的新方法。
OBJECTIVE to improve the drug release reproducibility of elementary osmotic pump tablets and to investigate its drug release mechanism with a new method.
应用推荐